pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LIOCYXM-004
Hepatocellular Carcinoma
Lion TCR Pte Ltd
0
catalysts
Preclinical
LIRAGLUTIDE
LIRAGLUTIDE (LIRAGLUTIDE)
Diabetes
$LEXX
Lexaria Bioscience Corp.
0
catalysts
Phase 2
LIS-1
Kidney Transplant Rejection
Xenothera SAS
0
catalysts
Phase 1
LIS-22
← prev
page 118 of 271
next →
131
Pain
89
Neurology
1
Peripheral T-Cell Lymphomas (PTCL)
Xenothera SAS
0
catalysts
LISINOPRIL AND HYDROCHLOROTHIAZIDE
LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)
COREPHARMA
0
catalysts
LITHIUM
LITHIUM (LITHIUM)
RUBICON RESEARCH
0
catalysts
LIVDELZI
LIVDELZI (SELADELPAR LYSINE)
1 INDICATIONS AND USAGE LIVDELZI is indicated for the treatment of primary bi…
Peroxisome proliferator-activated receptor delta
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Preclinical
LLS-30
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Kibio Inc
0
catalysts
Phase 2
LM-11A31BHS
Alzheimer's Disease
PharmatrophiX Inc
0
catalysts
Phase 2
LM-24C5
Solid Tumor
LaNova Medicines Ltd
0
catalysts
Phase 3
LMN-201
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lumen Bioscience Inc
0
catalysts
Phase 2
LMP-744
Recurrent Glioblastoma Multiforme (GBM)
Gibson Oncology LLC
0
catalysts
Phase 1
LMY-920
Mantle Cell Lymphoma
Luminary Therapeutics Inc
0
catalysts
Phase 2
LN-145
lifileucel
Non-Small Cell Lung Cancer
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
0
catalysts
Phase 1
LNCB-74
Bile Duct Cancer (Cholangiocarcinoma)
$NXTC
NextCure, Inc.
0
catalysts
Phase 3
LNS-8801
Metastatic Melanoma
Linnaeus Therapeutics Inc
0
catalysts
Phase 2
LNTH-2403
Osteosarcoma
$LNTH
Lantheus Holdings, Inc.
0
catalysts
LOARGYS
LOARGYS (PEGZILARGINASE-NBLN)
Immedica Pharma AB
0
catalysts
Phase 2
LOAd-703
Pancreatic Ductal Adenocarcinoma
Lokon Pharma AB
0
catalysts
LOCAMETZ
LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE)
NOVARTIS
0
catalysts
LOFEXIDINE
LOFEXIDINE (LOFEXIDINE)
REGCON HOLDINGS
0
catalysts
LOJAIMIESS
LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS)
XIROMED
0
catalysts
Preclinical
LON-21
Huntington Disease
ONeSTX Ltd
0
catalysts
LOPERAMIDE HCL AND SIMETHICONE
LOPERAMIDE HCL AND SIMETHICONE (LOPERAMIDE HCL AND SIMETHICONE)
SUN PHARM INDS LTD
0
catalysts
Marketed
LOPRESSOR
LOPRESSOR (METOPROLOL TARTRATE)
Angina (Angina Pectoris)
Rubicon Research Ltd
0
catalysts
Marketed
LORAZEPAM
LORAZEPAM (LORAZEPAM)
Anxiety Disorders
Graviti Pharmaceuticals Pvt Ltd
0
catalysts
LORBRENA
LORBRENA (LORLATINIB)
1 INDICATIONS AND USAGE LORBRENA ® is indicated for the treatment of adult pa…
ALK tyrosine kinase receptor
EML4-ALK
$PFE
PFIZER INC
0
catalysts
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)
Macleods Pharmaceuticals Ltd
0
catalysts
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE)
Alembic Pharmaceuticals Inc
0
catalysts
Phase 1
LP-102
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lpoxy Therapeutics Inc
0
catalysts
